A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies

NCT06038058 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancies

Interventions

DRUG: BRY812 for injection

Sponsor

BioRay Pharmaceutical Co., Ltd.